Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

345 ARTÍCULOS , VIENDO DEL 316 AL 330

Angiotensin-receptor blockers, hypertension and Alzheimer disease--the entangled relationship

Katayama T, Hasebe N.

Circ J. 2013;77(2):315-6. doi: 10.1253/circj.cj-12-1550. Epub 2012 Dec 22.

Effect of cholinesterase inhibitors on attention

Pepeu G, Giovannini MG, Bracco L.

Chem Biol Interact. 2013 Mar 25;203(1):361-4. doi: 10.1016/j.cbi.2012.09.016. Epub 2012 Oct 6.

Telomere shortening and Alzheimer's disease

Cai Z, Yan LJ, Ratka A.

Neuromolecular Med. 2013 Mar;15(1):25-48. doi: 10.1007/s12017-012-8207-9. Epub 2012 Nov 16.

New horizons for diagnostics and therapeutic applications of graphene and graphene oxide

Feng L, Wu L, Qu X.

Adv Mater. 2013 Jan 11;25(2):168-86. doi: 10.1002/adma.201203229. Epub 2012 Nov 19.

Application of behavior-based ergonomics therapies to improve quality of life and reduce medication usage for Alzheimer's/dementia residents

Mowrey C, Parikh PJ, Bharwani G, Bharwani M.

Am J Alzheimers Dis Other Demen. 2013 Feb;28(1):35-41. doi: 10.1177/1533317512467678. Epub 2012 Nov 29.

Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease

Chaudhary S, Scouten A, Schwindt G, Janik R, Lee W, Sled JG, Black SE, Stefanovic B.

J Magn Reson Imaging. 2013 Jul;38(1):26-35. doi: 10.1002/jmri.23967. Epub 2012 Dec 13.

Gender, sex steroid hormones, and Alzheimer's disease

Vest RS, Pike CJ.

Horm Behav. 2013 Feb;63(2):301-7. doi: 10.1016/j.yhbeh.2012.04.006. Epub 2012 Apr 19.

Delusions of Korean patients with Alzheimer's disease: study of drug-naïve patients

Kwak YT, Yang Y, Kwak SG, Koo MS.

Geriatr Gerontol Int. 2013 Apr;13(2):307-13. doi: 10.1111/j.1447-0594.2012.00897.x. Epub 2012 Jun 15.

A review of epidemiological evidence for general anesthesia as a risk factor for Alzheimer's disease

Seitz DP, Reimer CL, Siddiqui N.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Dec 2;47:122-7. doi: 10.1016/j.pnpbp.2012.06.022. Epub 2012 Jul 4.

Hierarchical Bayesian cognitive processing models to analyze clinical trial data

Shankle WR, Hara J, Mangrola T, Hendrix S, Alva G, Lee MD.

Alzheimers Dement. 2013 Jul;9(4):422-8. doi: 10.1016/j.jalz.2012.01.016. Epub 2012 Nov 2.

Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment

Grill JD, Karlawish J, Elashoff D, Vickrey BG.

Alzheimers Dement. 2013 May;9(3):356-359.e1. doi: 10.1016/j.jalz.2012.03.001. Epub 2012 Nov 8.

The impact of alcohol on Alzheimer's disease: a systematic review

Piazza-Gardner AK, Gaffud TJ, Barry AE.

Aging Ment Health. 2013;17(2):133-46. doi: 10.1080/13607863.2012.742488. Epub 2012 Nov 21.

Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease

Trzepacz PT, Cummings J, Konechnik T, Forrester TD, Chang C, Dennehy EB, Willis BA, Shuler C, Tabas LB, Lyketsos C.

Int Psychogeriatr. 2013 May;25(5):707-19. doi: 10.1017/S1041610212002141. Epub 2012 Dec 21.

Auditory cortical function during verbal episodic memory encoding in Alzheimer's disease

Dhanjal NS, Warren JE, Patel MC, Wise RJ.

Ann Neurol. 2013 Feb;73(2):294-302. doi: 10.1002/ana.23789. Epub 2012 Dec 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias